| Identification | Back Directory | [Name]
13,17-Nitrilo-5H,17H-pyrimido[4',5':3,4]pyrazolo[1,2-a][1,2]diazacyclotridecin-5-one, 7,10,11,12-tetrahydro-12-hydroxy-12-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-, (8Z,12R)- | [CAS]
2510782-14-4 | [Synonyms]
13,17-Nitrilo-5H,17H-pyrimido[4',5':3,4]pyrazolo[1,2-a][1,2]diazacyclotridecin-5-one, 7,10,11,12-tetrahydro-12-hydroxy-12-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-, (8Z,12R)- | [Molecular Formula]
C28H32N8O2 | [MOL File]
2510782-14-4.mol | [Molecular Weight]
512.61 |
| Hazard Information | Back Directory | [Uses]
WEE1-IN-9 (Compound 1) is a Wee1 inhibitor that can be used in cancer research[1]. | [References]
[1] Qian W, et al. Macrocyclic compound serving as Wee1 inhibitor and applications thereof. U.S. Patent. WO2019085933. 2019-05-09. |
|
|